Objectives: Incidental findings (IF) are becoming increasingly common due to the proliferation of imaging research. IFs can be life-changing for ''healthy'' volunteers. This study examined variation in IF management in UK research studies of healthy volunteers, including comparison with ethical and legal guidelines, thus providing baseline data and informing future practice. Methods: Questionnaire of participant background [medical/non-medical; radiologist/non-radiologist; years as principal investigator (PI)], type of research (involving children or not), institutional policy, volunteer information, radiologist involvement in reporting scans and IF disclosure mechanisms. Investigator's current and perceived ''ideal'' practice was examined. Participants were PIs performing imaging research of healthy volunteers approved by UK ethics committees (2006)(2007)(2008)(2009). Results: 63/146 (43%) surveys completed. 54/61 (88.5%) had site-specific guidelines. Information commonly provided to volunteers should IF be found: personal data (51/62; 82%), contingency plans (54/62; 87%) and disclosure to general practitioner (GP)/treating physician (47/62; 76%). PIs used different strategies for image review. Commonest: radiologist reports research scans only when researcher suspicious of IF [15/57 (26%) compared with 5/28 (16%) in ideal practice]. Commonest ideal reporting strategy: routine reporting by specialist radiologists [9/28 (29%) compared with 8/57 (14%) in current practice]. 49/56 (87.5%) have a standardised disclosure contingency plan, usually involving GP. PIs most commonly disclosed IFs to volunteers when judged relevant (27/58; 47%), most commonly face to face (22/54; 41%), by volunteer's GP (26/ 60; 43%). Background of PI influenced consent, reporting and disclosure practice. Conclusion: There is wide variation in handling IFs in UK imaging research. Much of the current practice contravenes the vague existing legal and ethical guidelines, and is unlikely to be in the best interests of volunteers or researchers.
The term ''incidental finding'' may give the impression that an unexpected finding is trivial, but an incidental finding (IF) can be life-changing [1] . One definition is ''a finding that has potential health or reproductive importance which is discovered in the course of conducting research, but is beyond the aims of the study'' [2] . The wider use of imaging in research is making incidental imaging findings more common, and recent academic and popular press editorials have highlighted the need for better management [3, 4] . Advancing research practice is controversial and has led to recent debate [5] and deadlock [6] among imaging researchers in Europe and North America.
IFs are common in research imaging. Their prevalence on brain MRI was 2.7% across 16 studies involving 19 559 participants [7] and may be as high as 12.8% on body MRI [8] . Extracolonic IFs at CT colonography require further investigation, medical or surgical intervention in 5-8% [9] . There are, therefore, important implications for informed consent, clinical review of images and mechanisms for notifying the subject. For the volunteers themselves, an IF may have serious implications for health, employment, medical or life insurance, and their state of mind. Furthermore, irrelevant imaging features incorrectly identified as pathological by non-radiologically trained researchers may cause unnecessary distress.
We recently reviewed UK, European and other international legal and ethical guidance on management of IFs, and limited available information on volunteers' expectations. Current recommendations are consistent with the principles that research volunteers should be informed of how their research images will be managed, that there should be measures for identifying and acting on IFs, and information should be disclosed to the subject and his or her responsible physician in a timely, sensitive and appropriate manner [10] . However, this guidance is hard to find and ambiguous, and does not distinguish management of imaging from other types of research sample. We suspected that management of IFs varies considerably between imaging research centres, but lacked reliable data on current practice. We have therefore surveyed UK imaging researchers to determine how IFs are currently managed to provide baseline data to inform future UK practice.
Methods

Participants
The UK National Research Ethics Service (NRES) provided written confirmation that ethical approval was not necessary for this questionnaire-based study (Ref: 04/ 12) . Eligible participants were lead or principle investigators (PIs) of at least one imaging research study using ''healthy'' volunteers between 2006 and 2009 that had been approved by a UK ethics committee. No national database of imaging researchers exists; we therefore identified potential participants' contact details through research institution websites, and by liaison with relevant managers, heads of departments and known researchers.
Survey design
We produced hard-copy and automated internet versions of the questionnaire (SurveyMonkey.com, Portland, OR). We used tailored design and bimodal methodology for internet surveys to optimise quality and participant response [11] [12] [13] [14] . All responses were anonymous. The definition of an IF was highlighted at the start of the questionnaire [2] . PIs were asked to answer the questionnaire in relation to their latest imaging study and to confirm that they had ethics approval for that study. We sought information on participant background (medical/ non-medical; radiologist/non-radiologist; number of years as PI), type of research (involving children or not), any policy on IFs at their site, information given to volunteers, involvement of radiologists in reporting of scans and mechanisms for disclosure of any IFs (Appendix A). We defined medical as possessing a medical degree (Bachelor of Medicine and Surgery, or equivalent) and currently practising medicine. We sought information both on current practice and on what PIs considered to be ideal practice (defined as ''practice without funding or time constraints'').
Statistical analysis
We compiled data from the completed questionnaires in Microsoft Excel (Microsoft Corp., Seattle, WA) and tested for normality (http://home.ubalt.edu/ntsbarsh/ Business-stat/otherapplets/Descriptive.htm). We used the two-tailed Yates corrected x 2 test (or for small numbers Fisher's exact test) for comparisons between groups (http://statpages.org/ctab2x2.html), except for nonparametric continuous and ordered categorical data (e.g. size of institution, years as PI, trends in reporting), in which cases we used the two-tailed Mann-Whitney U-test (http://elegans.swmed.edu/,leon/stats/utest.cgi). Statistical significance was set at p,0.05. The null hypothesis was that there would be no difference between PIs in current UK practice in the management of IFs; we also explored differences in ideal practice.
Results
Subject characteristics
We identified 160 potential participants, although 3 (2%) could not be contacted and 14 (9%) said that they were ineligible. Of the 146 eligible participants, 63 (43%; on an ''intention to survey'' basis) completed the questionnaire (Table 1 Site-specific guidelines 61 respondents answered this question, of whom 54 (88.5%) had site-specific guidelines, 47 (77%) giving a brief description. Here, most PIs explained that research ethics committee approval was required. Type of PI (medical and non-medical, p50.69; radiologist and nonradiologist, p50.38), subject (children or adults, p50.31), years as PI (p50.14) and size of institution (p50.88) were not associated with whether an institution had guidelines.
Consent
Most PIs currently provide information to volunteers on handling of personal data (51/62; 82%), contingency plans (54/62; 87%) and disclosure to a general practitioner (GP)/treating physician (47/62; 76%) should an IF be found (Questions 1-3 in Table 2 ). Most PIs do not currently provide other information listed in Table 2 (Questions 4-9), and even fewer PIs thought it ideal to provide volunteers with this information.
Medical PIs were more likely than non-medical PIs to indicate that IFs would be disclosed to the volunteer by a member of the research team (p,0.0001), to indicate whether any IFs were likely to be treatable (p50.047) and to indicate whether there would be potential future recontact if the data were to be re-analysed (p50.017). Radiologists were more likely than non-radiologists to discuss potential benefits of identifying any incidental lesion (p50.048). The number of years as PI and type of research subjects was not associated with this aspect of practice.
The only difference in ideal practice was that medical PIs were more likely than non-medical PIs to opt for discussion with volunteers regarding the investigator's Bachelor of medicine and surgery (or equivalent) and currently practicing medicine. (26) 5. Whether any incidental findings are likely to be treatable 13 (21) 11 (18) 6. Potential benefits of any incidental findings should they be found (e.g. prophylactic intervention)
16 (26) 13 (21) 7. Potential harms of any incidental findings should they be found (e.g. medical insurance being affected)
19 (31) 19 (31) 8. The extent (if any) of the investigator's responsibility to provide medical services should any incidental finding be found 26 (42) 19 (31) 9. Potential future re-contact in anticipation that the data be re-analysed in the future after this project has finished 23 (37) 20 (32) a PIs were informed that they could choose more than one option. Examples are: (a) a suitable mechanism is always in place for disclosure of an incidental finding to the volunteer; (b) the plan is to always not disclose.
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responsibility to provide medical services should any IF be found (p50.036).
Radiology reporting
57 (90%) and 28 (44%) of 63 respondents answered the question on radiologist involvement in research imaging in current and ideal practice, respectively (Figure 1 ). Strategies for image review varied; the most common current policy (15/57; 26%) was to request radiologists to report research scans only when a researcher was suspicious of an IF, although only 5/28 (16%) considered this ideal practice. The commonest ideal reporting strategy was for routine reporting by specialist radiologists 9/28 (29%), but this was current practice for only 8/57 (14%) PIs.
Medically trained PIs were more likely than nonmedical PIs to take a proactive approach (i.e. radiologist reporting of all scans, obtaining additional scans routinely, specialist reporting or combinations thereof) to identify IFs (p50.041). The tendency towards proactive image review and specialist reporting was even more marked when radiologist PIs were compared with nonradiologists (p50.007). However, no other PI or subject characteristics were associated with research scan reporting strategy or trend in current or ideal practice.
Disclosure of findings
Of the 56 respondents who answered whether their institution had a standardised contingency plan for disclosure of IFs, 49 (87.5%) confirmed such an arrangement. 35 (62.5%) gave a brief description; in most cases the GP would be informed of any IF. All (26/26) respondents felt that standardised contingency plans were ideal practice.
We received a variety of responses to when, how and by whom IFs were disclosed to volunteers (Table 3) . PIs most commonly disclosed IFs to volunteers when judged relevant (27/58, 47%), and a similar percentage thought this ideal (12/26, 46%). Face-to-face disclosure was the most common method of communication (22/54, 41%), and was thought by many to be ideal (19/27, 70%). Disclosure was most commonly by the volunteer's GP (26/60, 43%), which was also thought ideal practice (9/28, 32%).
Non-medical PIs were significantly more likely never to disclose IFs to the volunteer (p50.003). The two common reasons given were that non-clinicians process the images (6/12), and that disclosure was harmful and caused stress to the volunteer (5/12). No difference in ideal practice was found between medical and nonmedical PIs.
Those who had been PIs for a shorter period of time were more likely to disclose IFs routinely to the volunteer than those who had been PIs for a longer period (p50.042), but more experienced investigators were more likely than less experienced researchers to disclose IFs to the volunteer if felt to be relevant (p50.020). There were no other differences in either ideal or current practice by PI type or research subject characteristics.
Medical PIs were more likely to use a research team physician than non-medical researchers, as were radiologists compared with non-radiologists (both p,0.001). Here, PIs described what they meant by ''other''. Several explained that rather than deciding themselves whether to disclose an incidental finding or not, it was the GP or medical practitioner who made that decision. 
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Non-medical researchers were more likely to use the volunteer's own GP in current practice (p,0.001) and also felt this was ideal practice (p50.033).
Discussion
Summary of findings
This survey captured information from almost half of all UK PIs, using healthy volunteers in research imaging, whom we were able to contact through postal and e-mail approaches. Although nearly 90% of respondents had site-specific guidelines for handling IFs in healthy volunteers, we found that this guidance, and the way it is applied, varies widely between sites. Specifically, we demonstrated considerable variation in current practice with regard to (a) information given to volunteers during consent, (b) research scan reporting strategies and (c) the mechanisms of disclosing IFs. Differences in consent, reporting and disclosure practice were associated with investigator background -notably, whether they were medically trained or radiologists, and their level of experience. We additionally obtained views on ideal practice, which we defined as ''practice without funding or time constraints'', which also varied among researchers and almost always differed from current practice.
Strengths and weaknesses of the study
Inclusion of only PIs of recent imaging studies, the mixed background characteristics of investigators and the high response rate suggest that the results represent a reasonable cross-section of current UK practice. Our questionnaire was comprehensive and likely to capture the key details of how IFs are currently handled. Nonetheless, this study has limitations. The database used for recruitment was inevitably incomplete, and respondents may represent a biased subgroup. Approximately half the respondents gave no opinion as to what they considered to be ideal practice, reducing the sample size for this aspect of the study; the reasons for poor response in this part of the survey are uncertain. Moreover, although the questionnaire was designed with care, responses may reflect varying interpretation of the questions.
Comparison with studies worldwide
There is limited published data on practice in handling incidental imaging findings in healthy volunteers; all such data are from outside the UK [9, 15, 16] , and the primary aims of those studies differed from our survey. Wider interpretation of previous studies is also limited by low response rate (11%) [16] , small sample (12 researchers) [9] or their scope, such as analysis of information from research websites only [15] . Some comparisons can, however, be made with these studies performed outside the UK:
N There is wide variability in reporting strategies, with routine radiologist involvement in less than half of all practices, in accordance with the findings of Illes et al (43% in our survey compared with 33% in their United States-based study) [16] .
N We showed that 12.5% of UK PIs do not have standardised contingency plans for disclosure of IFs. This is lower than the 47% found among neuroimaging investigators in the United States [16] and the 80% in a more general survey of Canadian research institution activity, which also included handling of non-imaging research data [17] .
N With regard to disclosure, the commonest approach was to disclose relevant IFs in contrast to Siddiki et al, who found the most frequent strategy was routine disclosure (47% in our study compared with Siddiki et als' 42% for relevant reporting; 26% in our study compared with Siddiki et als' 58% for routine reporting) [9] . 19% of PIs in our study never disclosed IFs, compared with ,11% in a United States study that also incorporated genomic research [15] . N 37% of PIs warned volunteers that re-analysis of the data in the future may lead to re-contact after the study has finished. This compares with only 4% in the United States combined imaging and genomic study [15] .
Study explanations and relevance from a national and international perspective Consent
Information provided during consent is inadequate in a notable minority of practice. Although this compares favourably with available data on United States practice, the lack of clear contingency arrangements in over 10% of our sample falls short of mandatory UK NRES requirements that all volunteers are adequately informed about contingency plans, potential benefits and harms should any IFs be found [18] . Not informing the volunteer about who is handling their personal data and for what purposes also contravenes the UK Data Protection Act [19] . Our finding that radiologists were more likely than non-radiologists to discuss potential implications of IFs is likely to reflect greater familiarity with common IFs and the issues that they raise.
Only about 20% of PIs discussed whether any IFs are likely to be treatable, which is a European ''Additional Protocol'' requirement [20] . This practice was, not f Here, PIs described what they meant by ''variable''. Most explained that the person disclosing the incidental finding varies depending on the circumstance. Therefore, it may be appropriate for a radiologist, physician, GP, treating physician or a nurse to disclose, depending on the situation. g Here, it was unknown who would disclose to the volunteer as historically no incidental findings had been discovered. h Respondents could select more than one item.
i PIs described what they meant by ''other''. Most explained that non-clinical staff reviewed scans therefore disclosure was inappropriate. 
WHO/UNESCO also recommend discussion prior to consent of ''the extent of the investigator's responsibility to provide medical services to the participant'' should an IF be discovered [21] . This ethical guideline is followed by 42% of PIs in current UK practice; here, medical PIs were more likely than non-medical PIs to advocate this as ideal practice.
Just over one-third of PIs warned volunteers that reanalysis of the data in the future may lead to re-contact after the study has finished. This compares to only 4% in the United States [15] , although routinely giving such information is recommended there [2] . The higher percentage in the UK may reflect the legal obligation under the Data Protection Act [19] , which underpins the NRES instruction [18] . Medical PIs were more likely than nonmedical PIs to discuss re-contact, which may again reflect differences in perception of wider implications and limits of researchers' responsibilities.
Reporting
Our findings on radiological reporting suggest wide variation in practice, which ranged from no radiological review of images, through reactive policies (where radiological advice was sought only if an abnormality was noticed by a researcher or radiographer) through to proactive (all images reviewed by a radiologist) and very proactive (where additional imaging was performed routinely to better identify and characterise any incidental abnormalities) reporting [10] . Medical PIs, especially radiologists, tended towards more proactive reporting strategies compared with non-medical investigators.
The only specific UK guidelines on this subject were Medical Devices Agency recommendations that research MRIs are routinely reported by a radiologist [22] . These have recently been superseded by more vague guidelines from the UK Medicines and Healthcare products Regulatory Agency (MHRA) [23] .
The reasons for investigators not undertaking routine radiological reporting may reflect lack of access to radiological expertise (particularly for those working in centres not affiliated to clinical services), cost limitations, limited awareness of the frequency and implications of IFs, and opinions as to the extent of responsibility of the study investigator with regard to detection of such abnormalities [24] . Furthermore, policies of no reporting or reactive reporting are sometimes justified on the grounds that detection of IFs lies outside the remit of the research study [25] . This may, however, be counter to subject's expectations [26, 27] . Routine proactive radiological review of research images is likely to provide more sensitive and specific detection of significant incidental abnormalities [24] . The benefit to the subject will clearly be greatest where detection of pre-symptomatic treatable disease improves outcome [10] . The images acquired for research studies are often not optimal for detection of disease [24] , such that a very proactive approach is advocated by some in the United States on ethical grounds [28] or to avoid litigation [29] . To optimise scientific integrity of studies [5] and facilitate appropriate follow-up [30, 31] , these strategies may additionally benefit from specialist radiologist involvement (e.g. a neuroradiologist reviewing brain MRI). Our data suggest that proactive policies have also been adopted in a number of UK centres. The advantages of proactive reporting must, however, be balanced against arguments that the purpose of imaging in such studies is not to screen for unexpected pathology [25] , minimal evidence base demonstrating benefit and cost implications [10, 24] .
Policies for review of research imaging in this context remains a controversial area (Appendix B) [5] , with particular disparities between clinical and non-clinical imaging groups.
Disclosure
There was variation in practice regarding disclosure of IFs. In the UK, unless the volunteer requests it [19] , there is no obligation for IFs to be disclosed [10] . The UK MHRA and WHO/UNESCO recommend that IFs are routinely disclosed during MRI [23] and all [21] research, respectively. Although the adverse effects of disclosure include anxiety, which may be considered unnecessary if the IF is subsequently shown to be of no clinical importance [2, 32] , available evidence suggests that volunteers always want to be informed of such findings [26, 27] .
More experienced researchers tended to base decisions to disclose on whether findings were relevant. Disclosure of relevant IFs is concordant with the European Additional Protocol [20] . Only a small percentage of unexpected findings are clinically relevant [33] , and some investigators consider it unwise to communicate any except those that are most certain and clinically important [2, 6, 34] .
There are a number of possible reasons for the differences in disclosure policies between medical and nonmedical researchers. Non-medical investigators are likely to be less informed about the significance of a finding. Moreover, non-medical investigators' experience will be primarily of a researcher-subject relationship, separate from wider health concerns, whereas medical investigators are familiar with an increasingly non-paternalistic model of the doctor-patient relationship [35] , in which sharing of information with the patient is a central doctrine.
Only clinical professionals disclosed IFs to volunteers, consistent with the view that any disclosure to a volunteer is best done by a medical practitioner experienced in communicating sensitive medical information [10] . This goes beyond the European Additional Protocol statement that relevant IFs should be disclosed within a framework of healthcare or counselling, with an appropriate clinical professional supervising the research, although not explicitly disclosing any results themselves [20] .
Disclosure was slightly more commonly performed by GPs (43%) than by research team physicians (32%). This accorded broadly with ideal practice, but differs from wishes expressed by United States volunteers in which there was a strong preference for research team (59%) compared to the primary care physician (6%) [27] . The differences may arise in part from the different healthcare models and volunteers' relationships with primary care in the United States. The variability in who discloses IFs in the UK is probably pragmatic, as there is no current guidance. However, implications can be drawn from the UK Department of Health guidance that volunteers' GPs
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Unanswered questions and future directions
The wide variation in the handling of IFs in the UK is unlikely to be in the best interests of volunteers. Although many issues around consent and disclosure are covered by existing domestic legal and international ethical frameworks, implementation and compliance vary. In the UK and other nations there are no clear national guidelines on imaging review and reporting. Consequently, minimal acceptable standards that accord with informed consent and volunteers' expectations and best interests need to be established. Discrepancies between UK researchers' existing and perceived ideal arrangements may reflect resource constraints, and provide impetus for cost-effective strategies for bridging the gap between current and best practice. Discussion of UK research practice for handling IFs is therefore needed, and will require representation from both clinical and nonclinical researchers, GPs, and patients' representatives. This will allow consensual establishment of practical, lawful and ethically defensible UK national guidelines that can inform NRES advice to ethics committees, and perhaps set a precedent for other nations.
Appendix B
A selection of comments invited following survey completion.
N I do not believe that it is cost effective or practical to require additional ''clinical'' scans and radiological reading on all studies. I believe our current practice of following up only on suspicious findings, and clearly badging the imaging we do as ''research that may have no diagnostic value'', is the right one.
N If scans are routinely reported it would add significantly to the costs of research, for no obvious gain.
N The reporting is time-consuming and not trivial, but having run a research scanner for twelve years and research imaging on (UK) National Health Service scanners before that, we have decided that there isn't any other ethical way of doing it. It's not fair on the volunteer not to look after their scan findings.
N Long overdue. We must implement a standardised best practice across all institutions which have imaging equipment capable of detecting pathology. Too many ''toys'' are being installed in basic science/ physics/psychology departments without a clear understanding of the ethical implications.
